Coagulation disorders: Inflammation and thrombosis

Neonatology: A Practical Approach to Neonatal Diseases

Volumn , Issue , 2012, Pages 770-774

  Armstrong Wells, Jennifer L ^a   Manco Johnson, Marilyn J ^a  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84897481383     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1405-3_101     Document Type: Chapter

References (37)

1. Esmon CT (2005) The interactions between inflammation and coagulation. Brit J Haematol 131: 417-430
2. Martorell L, Martinez-Gonzalez J, Rodriguez C et al (2008) Thrombin and protease-activated receptors (PARs) in atherothrombosis. Thromb Haemost 99: 305-315
3. Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979
4. Fox EA, Kahn SR (2005) The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost 94: 362-365
5. Redline RW (2006) Inflammatory responses in the placenta and umbilical cord. Semin Fetal Neonat Med 11: 296-301
6. Redline RW (2005) Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol 192: 452-457
7. Ramaswarmy V, Horton J, Vandermeer B et al (2009) Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 40: 215-226
8. Polydorides AD, Kalish RB, Witkin SS, Baergen RN (2007) A fetal cyclooxygenase-2 gene polymorphism is associated with placental malperfusion. Int J Gynecol Pathol 26: 284-290
9. Hausman N, Beharry K, Nishihara K et al (2003) Antenatal administration of celecoxib, a selective cyclooxygenase (COX)-2 inhibitor, appears to improve placental perfusion in the pregnant rabbit. Prostaglandins Other Lipid Mediat 70: 303-315
10. Papafili A, Hill MR, Brull DJ et al (2002) Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc Biol 22: 1631-1636
11. Cipollone F, Toniato E, Martinotti S et al (2004) A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA 291: 2221-2228
12. Reddy S, Jia S, Geoffrey R (2009) An autoinflammatory disease due to homozygous deletion of the IL1RN locus. N Engl J Med 360: 2438-2444
13. Hartel C, Konig I, Koster S et al (2006) Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants. Pediatrics 118: 683-689
14. Lee J, Croen LA, Backstrand KH et al (2005) Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 293: 723-729
15. Wu YW, Escobar GJ, Grether JK et al (2003) Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 290: 2677-2684
16. Golomb MR (2003) The contribution of prothrombotic disorders to peri-and neonatal ischemic stroke. Semin Thromb Hemost 29: 415-424
17. Armstrong-Wells J, Johnston SC, Wu YW (2009) Prevalence and Predictors of Perinatal Hemorrhagic Stroke. Pediatrics 123: 823-828
18. Wu YW (2002) Systematic review of chorioamnionitis and cerebral palsy. Ment Retard Dev Disabil Res Rev 8: 25-29
19. Nelson KB (2006) Thrombophilias, perinatal stroke, and cerebral palsy. Clin Obstet Gynecol 49: 875-884
20. Tincani A, Bazzani C, Zingarelli S, Lojacono A (2008) Lupus and the antiphospholipid antibody syndrome in pregnancy and obstetrics: clinical charcteristics, diagnosis, pathogenesis and treatment. Semin Thromb Hemost 34: 267-272
21. Ruffatti A, Tonello M, Cavazzana A et al (2009) Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 123: 482-487
22. Silver RK, MacGregor SN, Pasternak JF, Neely SE (1992) Fetal stroke associated with elevated maternal anticardiolipin antibodies. Obstet Gynecol 80: 497-499
23. Boffa MC, Lachassinne E (2007) Infant perinatal thrombosis and antiphospholipid antibodies: a review. Lupus 16: 634-641
24. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70: 427-451
25. Wheeler RD, Boutin H, Touzani O et al (2003) No role for interleukin-18 in acute murine stroke-induced brain injury. J Cereb Blood Flow Metab 23: 531-535
26. Wheeler RD, Brough D, LeFeuvre RA et al (2003) Interleukin-18 induces expression and release of cytokines from murine glial cells: interactions with interleukin-1 beta. J Neurochem 85: 1412-1420
27. Conrad KP, Benyo DF (1997) Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 37: 240-249
28. Conrad KP, Miles TM, Benyo DF (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40: 102-111
29. Ramaswamy V, Horton J, Vendermeer B et al (2009) Systematic review of biomarkers of brain injury in term neonatal encephalopathy. Pediatr Neurol 40: 215-226
30. Girard S, Kadhim H, Roy M et al (2009) Role of perinatal inflammation in cerebral palsy. Pediatr Neurol 40: 168-174
31. Dammann O, O'Shea TM (2008) Cytokines and perinatal brain damage. Clin Perinatol 35: 643-663
32. Cholette JM, Ruberstein JS, Alfieris GM et al (2007) Elevated risk of thrombosis in neonates undergoing initial palliative cardiac surgery. Ann Thorac Surg 84: 1320-1325
33. Thornburg CD, Smith PB, Smithwick ML et al (2008) Association between thrombosis and bloodstream infection in neonates with peripherally inserted catheters. Thromb Res 122: 782-785
34. Manco-Johnson MJ (2006) How I treat venous thrombosis in children. Blood 107: 1-9
35. Monagle P, Chalmers E, Chan A et al (2008) Antithrombotic therapy in neonates and children. Chest 133: 887S-968S
36. Kosch A, Kuwertz-Broking E, Heller C et al (2004) Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood 104: 1356-1360
37. Nuss R, Hays T, Manco-Johnson M (1994) Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 16: 127-131